Summary of Key Points Core Viewpoint - Dongcheng Pharmaceutical (002675) has shown a positive trading performance with a closing price of 18.15 yuan, reflecting a 3.77% increase on August 6, 2025, alongside significant capital inflow from major investors [1]. Trading Information Summary - On August 6, 2025, Dongcheng Pharmaceutical experienced a net capital inflow of 33.21 million yuan from major investors, while retail investors saw a net outflow of 13.22 million yuan [1][3]. Company Announcement Summary - Dongcheng Pharmaceutical announced a guarantee contract with Industrial and Commercial Bank of China for a loan of 150 million yuan for its subsidiary, Yantai Dongcheng Dingnuo Biopharmaceutical Co., Ltd. This brings the total guarantee amount to 526.12 million yuan [1][3]. - The total guarantee amount provided by the company for its subsidiaries is now 526.12 million yuan, which represents 23.31% of the company's audited net assets for 2024 [1]. - The company has not provided guarantees for any entities outside its controlling subsidiaries, and there are no overdue guarantees or litigation issues related to these guarantees [1].

烟台东诚药业集团股份有限公司 关于为子公司及其下属公司提供担保的进展公告 证券代码：002675 证券简称：东诚药业 公告编号：2025-039 内容详见公司2025年2月27日和2025年3月29日刊载于《证券时报》、《证券 日报》、《中国证券报》、《上海证券报》和巨潮资讯网（www.cninfo.com.cn） 的《关于2025年度为子公司及其下属公司提供担保额度预计的公告》和《2024 年度股东大会决议公告》（公告编号：2025-013、2025-020）。 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 本次担保前，公司为合并报表范围内的子公司及其下属公司提供担保金额为 37,612万元；本次担保后，公司为合并报表范围内的子公司及其下属公司提供担 保总额52,612万元，可用担保额度为47,388元。 三、 被担保人基本情况 1 被担保人名称：烟台东诚鼎诺生物制药有限公司 法定代表人：孙晶 一、 本次担保情况概述 2025年8月6日，烟台东诚药业集团股份有限公司（以下简称"公司"）与中 国工商银行股份有限公司烟台开发区支行（以下简称"工商银行"或"债权 ...

Group 1 - The core business of Dongcheng Pharmaceutical is entirely focused on the biopharmaceutical industry, with a revenue composition of 100.0% from this sector for the year 2024 [1] Group 2 - Dongcheng Pharmaceutical announced on August 4 that its actual controller, You Shouyi, has lifted the pledge on part of the company's shares, specifically 1.96 million shares on August 1 [3] - As of August 4, 2025, You Shouyi holds approximately 103 million shares of Dongcheng Pharmaceutical, with a total of about 28.58 million shares pledged, representing 27.66% of the total shares held [3] - The overall risk associated with share pledges is considered manageable, and there is currently no risk of forced liquidation [3]

证券代码：002675 证券简称：东诚药业 公告编号：2025-038 烟台东诚药业集团股份有限公司 关于实际控制人部分股权解除质押的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 烟台东诚药业集团股份有限公司（以下简称"公司"、"本公司"或"东诚 药业"）近日收到公司实际控制人由守谊先生的通知，由守谊先生将其持有的本 公司部分股权进行解除质押，具体情况如下： 注：上表中比例合计数与各数值直接相加之和在尾数上存在差异，是由于数字四舍五入原因造成的。 三、股东股份是否存在平仓风险或被强制过户风险 根据《通知》所述，截至2025年8月4日由守谊先生持有东诚药业股票 103,305,678股，累计质押28,578,000股，累计质押股份占所持股份总数的27.66%； 股权质押风险总体可控，目前不存在平仓风险。 二、股东所持股份累计被质押的情况 截至公告披露日，实际控制人由守谊先生及其一致行动人所持质押股份情况 如下： | | | | | | 占公 | | 已质押股份情况 | | 未质押股份情况 | | | --- | --- | --- | --- | --- ...

Group 1 - The actual controller of the company, Mr. You Shouyi, has notified the company about the release of part of his pledged shares [1][2] - As of August 1, 2025, Mr. You holds 103,305,678 shares of Dongcheng Pharmaceutical, with a total of 30,538,000 shares pledged, accounting for 29.56% of his total holdings [1] - The overall risk of share pledging is controllable, and there is currently no risk of forced liquidation [1][2] Group 2 - The actual controller and his concerted actors have a good credit status and possess the ability to repay funds, thus there is no risk of forced liquidation or change in actual control [2] - The company will continue to monitor the pledge situation and will disclose relevant information in a timely manner as required [2]

Group 1 - The actual controller of Yantai Dongcheng Pharmaceutical Group Co., Ltd., Mr. You Shouyi, has notified the company about the release of part of his pledged shares, indicating that the overall risk of share pledge is controllable and there is currently no risk of forced liquidation [1][2] - As of the announcement date, Mr. You Shouyi and his concerted actors have pledged a total of 30,538,000 shares, which accounts for 29.56% of his holdings, while 46,941,258 shares remain unpledged, representing 64.51% of his total shares [2][4] - The company confirms that there is no risk of forced liquidation or compulsory transfer of shares, as the actual controller and his concerted actors have good credit status and sufficient funds to repay the pledged shares [4]

本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 烟台东诚药业集团股份有限公司（以下简称"公司"或"本公司"）近日收 到公司实际控制人由守谊先生的通知，由守谊先生将其持有的本公司部分股权进 行解除质押，具体情况如下： 根据《通知》所述，截至2025年8月1日由守谊先生持有东诚药业股票 103,305,678股，累计质押30,538,000股，累计质押股份占所持股份总数的29.56%； 股权质押风险总体可控，目前不存在平仓风险。 注：上表中比例合计数与各数值直接相加之和在尾数上存在差异，是由于数字四舍五入原因造成的。 证券代码：002675 证券简称：东诚药业 公告编号：2025-037 烟台东诚药业集团股份有限公司 关于实际控制人部分股权解除质押的公告 二、股东所持股份累计被质押的情况 | 名称 | （股） | 例 | 数量（股） | 持股份 | 司总 | 已质押股 | 占已质 | 未质押股 | 占未质 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | | 比例 | 股 ...

Market Overview - The three major A-share indices showed mixed performance on the morning of the 30th, with the Shanghai Composite Index rising by 0.52%, while the Shenzhen Component Index and the ChiNext Index fell by 0.06% and 0.71% respectively [2] - The total trading volume in the Shanghai and Shenzhen markets reached 1,102.2 billion yuan, a decrease of 43.6 billion yuan compared to the previous day [2] Sector Performance - The innovative drug and film industry sectors experienced gains, with stocks such as Nanjing New Pharmaceutical and Happiness Blue Sea hitting the daily limit of 20% [2] - The battery sector faced adjustments, with companies like Xinyu Ren and Zhengye Technology dropping over 5% [2] - The digital currency sector weakened, with Dongxin Peace falling more than 8% [2] - The diversified financial sector also saw fluctuations, with companies like Nanhua Futures and Zhongyou Capital declining over 5% [2]

本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 烟台东诚药业集团股份有限公司（以下简称"公司"或"本公司"）近日收 到公司实际控制人由守谊先生的通知，由守谊先生将其持有的本公司部分股权进 行解除质押，具体情况如下： 根据《通知》所述，截至2025年7月28日由守谊先生持有东诚药业股票 103,305,678股，累计质押41,568,000股，累计质押股份占所持股份总数的40.24%； 股权质押风险总体可控，目前不存在平仓风险。 二、股东所持股份累计被质押的情况 证券代码：002675 证券简称：东诚药业 公告编号：2025-036 烟台东诚药业集团股份有限公司 关于实际控制人部分股权解除质押的公告 截至公告披露日，实际控制人由守谊先生及其一致行动人所持质押股份情况 如下： | 已质押股份情况 | 未质押股份情况 | 占其所 | 占公司 | 股东 | 持股数量 | 持股比 | 累计质押数 | 持股份 | 总股本 | 已质押股 | 占已质 | 未质押股 | 占未质 | | --- | --- | --- | --- | --- | --- | --- | --- ...

Core Viewpoint - Dongcheng Pharmaceutical (002675) announced that its actual controller, Mr. Shouyi, has released a pledge on 1.21% of the company's shares [1] Summary by Relevant Sections - Share Pledge Details - Mr. Shouyi's cumulative pledged shares account for 40.24% of his total holdings [1] - Among the released pledged shares, 9.5 million shares were pledged starting from September 5, 2022, and 480,000 shares were pledged starting from August 21, 2024, both set to be released on July 25, 2025 [1]